Free Trial

Virios Therapeutics (VIRI) SEC Filings & 10K Form

Virios Therapeutics logo
$4.82 +0.13 (+2.77%)
As of 07/23/2025

Recent Virios Therapeutics SEC Filings

DateFilerForm TypeView
07/01/2025
12:52 PM
De La Rosa Abel (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
12:56 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Walsh Angela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
12:58 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Keefer David R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:00 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Duncan Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:02 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Thomas John C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:05 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Grosswald Ralph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:07 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Whitley Richard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:11 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Gendreau Roger Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:01 PM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/24/2025
9:15 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
10:57 AM
De La Rosa Abel (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
10:59 AM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Thomas John C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
11:02 AM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Keefer David R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
11:04 AM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Whitley Richard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
11:15 PM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form EFFECT
05/23/2025
4:25 PM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/09/2025
10:28 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
8:20 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
1:08 PM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form ARS
04/30/2025
7:00 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form DEF 14A
04/03/2025
8:10 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:44 PM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
7:19 PM
Conjoint Inc. (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/17/2025
8:11 PM
Virios Therapeutics (Subject)
Dogwood Therapeutics, Inc. (Subject)
Sealbond Ltd (Filed by)
Form SCHEDULE 13D/A
03/17/2025
8:07 PM
CK Life Sciences Intl Inc (0001297567) (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:53 PM
Virios Therapeutics (Subject)
Dogwood Therapeutics, Inc. (Subject)
Orca Capital AG (Filed by)
Form SCHEDULE 13G/A
03/17/2025
4:49 PM
Virios Therapeutics (Subject)
Dogwood Therapeutics, Inc. (Subject)
Orca Capital AG (Filed by)
Form SCHEDULE 13G
03/14/2025
10:47 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2025
9:32 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 424B5
03/12/2025
8:00 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
8:30 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K/A
11/21/2024
8:15 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:15 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:15 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
8:25 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:29 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Toh Kean Meng Melvin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/17/2024
3:30 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Yu Ying Choi Alan Abel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/17/2024
3:29 PM
CK Life Sciences Intl Inc (0001297567) (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Sealbond Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2024
3:19 PM
Sealbond Ltd (Filed by)
Virios Therapeutics (Subject)
Virios Therapeutics, Inc. (Subject)
Form SC 13D
10/07/2024
7:06 AM
Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
Form DEFA14A
10/07/2024
7:02 AM
Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
5 Stocks Poised to Soar Under Trump's Presidency (Ad)

With the next presidential cycle heating up and Trump leading the charge, major market shifts are already taking shape. For investors who position early, the opportunities could be significant. That’s why we’ve just released a brand-new report: 📈 “5 Best Stocks to Buy Under Trump’s Presidency.”

Get the full report here—and stay ahead of the curve.
08/09/2024
9:15 AM
Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
8:30 AM
Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VIRI) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners